NCT06880991View on ClinicalTrials.gov

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

RecruitingOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
Neurofibromatosis Type 1Neurofibroma
Interventions
OTHER

Arm 1

Participant completion of questionnaires and participation in focus group(s) and/or interview sessions.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH